Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

In this work, Lactiplantibacillus plantarum (L. plantarum) isolated from mice feces (LP-M) and pickles (LP-P) were chosen as the endogenous and exogenous L. plantarum, respectively, which were separately combined with chitosan oligosaccharides (COS) to be synbiotics. The anti-inflammatory activity of LP-M, LP-P, COS, and the synbiotics was explored using dextran-sodium-sulfate (DSS)-induced acute colitis mice, as well as by comparing the synergistic effects of COS with LP-M or LP-P. The results revealed that L. plantarum, COS, and the synbiotics alleviated the symptoms of mice colitis and inhibited the changes in short-chain fatty acids (SCFAs), tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, IL-10, and myeloperoxidase (MPO) caused by DSS. In addition, the intervention of L. plantarum, COS, and the synbiotics increased the relative abundance of beneficial bacteria Muribaculaceae and Lactobacillus and suppressed the pathogenic bacteria Turicibacter and Escherichia-Shigella. There was no statistically difference between LP-M and the endogenous synbiotics on intestinal immunity and metabolism. However, the exogenous synbiotics improved SCFAs, inhibited the changes in cytokines and MPO activity, and restored the gut microbiota more effectively than exogenous L. plantarum LP-P. This indicated that the anti-inflammatory activity of exogenous LP-P can be increased by combining it with COS as a synbiotic.

Keywords: Lactiplantibacillus plantarum; chitosan oligosaccharides; colitis; cytokines; gut microbiota; short-chain fatty acids.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactiplantibacillus plantarum LP-1Increased Abundance of MuribaculaceaeBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Increased Fecal LactobacilliBeneficial
Large
Lactiplantibacillus plantarum LP-1Inhibited Changes in Short-Chain Fatty AcidsBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Colitis SymptomsBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Interleukin-10 LevelsBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Interleukin-1β LevelsBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Interleukin-6 LevelsBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Myeloperoxidase ActivityBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Relative Abundance of Escherichia-ShigellaBeneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Tumor Necrosis Factor-α (TNF-α)Beneficial
Moderate
Lactiplantibacillus plantarum LP-1Reduced Turicibacter AbundanceBeneficial
Moderate
Lactiplantibacillus plantarum Lp-115Improved Abundance of Beneficial BacteriaBeneficial
Moderate
Lactiplantibacillus plantarum Lp-115Reduced Colitis SymptomsBeneficial
Moderate
Lactiplantibacillus plantarum Lp-115Reduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactiplantibacillus plantarum Lp-115Restored Gut Microbiota CompositionBeneficial
Moderate
Back to top